Literature DB >> 10406155

Survival after malignant tumors of the orbit and periorbit treated by exenteration.

F Mouriaux1, V Martinot, P Pellerin, P Patenotre, J F Rouland, G Constantinides.   

Abstract

PURPOSE: In order to further assess the survival value of orbital exenteration in malignant orbital and periorbital tumors.
METHODS: The charts of 44 patients exenterated for a neoplasm of the orbit or periorbit were reviewed in a retrospective study.
RESULTS: The overall 4-year survival was 45%. 26 patients had free margins on histological examination and 24 patients had developed local recurrence or metastasis. Local recurrence or metastasis were significantly more common in the group with transected margins than in the group with free-margins (p= 0.01). Survival between the group of patients with local recurrence or metastasis and the group without local recurrence or metastasis showed statistically significant difference (p=0.0025). In contrast, survival between the group of patients with free margins and the group with transected margins did not show statistically significant difference (p=0.13).
CONCLUSION: Surgical free margins section is a key element in successful cancer surgery but seems not the only prognosis variable.

Entities:  

Mesh:

Year:  1999        PMID: 10406155     DOI: 10.1034/j.1600-0420.1999.770316.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  10 in total

1.  Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival.

Authors:  R C Gerring; C T Ott; J M Curry; Z B Sargi; S T Wester
Journal:  Eye (Lond)       Date:  2016-10-21       Impact factor: 3.775

2.  Primary orbital rhabdomyosarcoma with skeletal muscle metastasis.

Authors:  Jayanta K Das; B K Tiwary; S B Paul; Harsha Bhattacharjee; Bhuyan Cida; Dipankar Das
Journal:  Oman J Ophthalmol       Date:  2010-05

3.  Mortality following exenteration for malignant tumours of the orbit.

Authors:  I Rahman; A Maino; A E Cook; B Leatherbarrow
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

Review 4.  Paranasal sinus cancer: caveats and controversies.

Authors:  John Waldron; Ian Witterick
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

5.  Prevention of postexenteration complications by obliteration of the orbital cavity.

Authors:  Jeffrey H Spiegel; Mark A Varvares
Journal:  Skull Base       Date:  2007-05

6.  Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India.

Authors:  Mohammad Javed Ali; Aditi Pujari; Tarjani Vivek Dave; Swathi Kaliki; Milind N Naik
Journal:  Int Ophthalmol       Date:  2015-08-07       Impact factor: 2.031

Review 7.  Can the onset of orbital cancer be the result of a prosthetic eye?

Authors:  A Croce; V Mastronardi; M Laus; E Festa Kotelnikova
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-12       Impact factor: 2.124

8.  Clinico-Pathological Patterns of Patients Who Underwent Orbital Exenteration in a Tertiary Eye Hospital of Nepal.

Authors:  Limbu Ben; Mengesha Aemero; Anya G Gushchin; Grant H Moore; Saiju Rohit
Journal:  Ethiop J Health Sci       Date:  2016-11

9.  Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series.

Authors:  Orapan Aryasit; Passorn Preechawai; Chakree Hirunpat; Orasa Horatanaruang; Penny Singha
Journal:  BMC Ophthalmol       Date:  2018-07-28       Impact factor: 2.209

10.  Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.

Authors:  Victorine Douin; Stephanie Bornes; Laurent Creancier; Philippe Rochaix; Gilles Favre; Anne-Catherine Prats; Bettina Couderc
Journal:  BMC Biotechnol       Date:  2004-07-27       Impact factor: 2.563

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.